<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000530324"><TermName>DT388IL3 fusion protein</TermName><TermPronunciation>(...FYOO-zhun PROH-teen)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of myeloid leukemia (a disease in which too many immature non-lymphocyte white blood cells are found in the blood and bone marrow). DT388IL3 fusion protein is made by combining IL-3 with a toxic substance. The IL-3 attaches to the cancer cells and the toxic substance kills them.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718774" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;DT388IL3 fusion protein&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718773" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;proteína de fusión DT388IL3&quot;" language="es" id="_4"/><SpanishTermName>proteína de fusión DT388IL3</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de la leucemia mieloide (una enfermedad en la cual se encuentran demasiados glóbulos blancos no linfocíticos en la sangre y la médula ósea). La proteína de fusión DT388IL3 se elabora combinando IL-3 con una sustancia tóxica. La IL-3 se une a las células cancerosas y la sustancia tóxica las destruye.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-05-04</DateFirstPublished></GlossaryTerm>
